Zoledronic Acid: all 272 studies that test it

Page 2 of 3. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.

• Zoledronic Acid Combined With EC-T for Triple-Negative Breast CancerActive, not recruitingNCT06876636Not applicable
• Muscle Impact of Treating OsteoporosisActive, not recruitingNCT05666310Phase 4
• Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2)Active, not recruitingNCT05655013Phase 4
• A Clinical Trial to Evaluate Efficacy of Once or Twice ZOledronic Acid After Different Duration of denOsumMab Administration in Postmenopausal Women With Osteoporosis (ZOOM Study)CompletedNCT05361408Phase 4
• Altering Bone Microarchitecture and Mechanics by Off-label Pharmaceutical Intervention Following an Acute Knee InjuryTerminatedNCT05204836Phase 1
• Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant LetrozoleStatus unknownNCT05164952Phase 3
• Denosumab vs Zoledronic Acid and Osteoporotic Compression FractureStatus unknownNCT05106517Phase 2/3
• The Optimal Sequential Therapy After Long Term Denosumab TreatmentCompletedNCT05091099Phase 4
• Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With LeiomyosarcomaCompletedNCT05080790Phase 2
• Zoledronic Acid for Prevention of Bone Loss After BAriatric Surgery (ZABAS)CompletedNCT04742010Phase 2
• Clinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic AcidStatus unknownNCT04719650Phase 4
• Effect of Zoledronic Acid on Prevention of Bone Loss in Acute Phase First-ever Stroke PatientsStatus unknownNCT04652128Not applicable
• Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (Z-AMD)CompletedNCT04304755Phase 2
• The Effect of Zoledronic Acid on Patients With Osteoarthritis of the HipStatus unknownNCT04303026Phase 3
• Bisphosphonates for the Treatment of Seropositive Musculoskeletal ComplaintsStatus unknownNCT04115397Phase 4
• Osteoporosis in Primary HyperparathyroidismStatus unknownNCT04085419Phase 4
• Multicentre Medical-economic Study Evaluating the Efficacy of Adding ZOlédronique Acid to STERéotaxique Radiotherapy in the Treatment of Vertebral MetastasesStatus unknownNCT03951493Phase 3
• Zoledronic Acid in Decrease the Lung Metastatic Rate of OsteosarcomaStatus unknownNCT03932071Phase 4
• Trial of Parkinson's And Zoledronic AcidCompletedNCT03924414Phase 4
• Denosumab Sequential TherapyCompletedNCT03868033Phase 4
• Zoledronic Acid in Combination With Interleukin-2 to Expand Vγ9Vδ2 T Cells After T-replete Haplo-identical AllotransplantCompletedNCT03862833Phase 1
• Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic AcidCompletedNCT03735537Phase 4
• Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)CompletedNCT03664687Phase 4
• Intravenous Bisphosphonate in Stress Fracture Treatment -A Randomised Controlled Double Blinded Multicenter TrialTerminatedNCT03576599Phase 4
• Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast CancerCompletedNCT03358017Phase 2
• Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer PatientsCompletedNCT03336983Phase 2
• Zoledronic Acid or Methylprednisolone for Active Charcot's Neuroarthropathy of Foot in Patients With Diabetes MellitusCompletedNCT03289338Phase 2/3
• Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b TrialActive, not recruitingNCT03173976Phase 1
• Generic Zoledronic Acid Versus Original Zoledronic Acid in Postmenopausal Osteoporotic WomenStatus unknownNCT03158246Phase 4
• Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic CancerActive, not recruitingNCT03073785Phase 2
• Denosumab Versus Zoledronic Acid in Thalassemia-Induced OsteoporosisTerminatedNCT03040765Phase 3
• Prevention of Periprosthetic Bone Loss After Total Hip Replacement by Annual Bisphosphonate TherapyCompletedNCT02838121Phase 3
• Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal TumorsCompletedNCT02784652Phase 2
• Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in OsteonecrosisStatus unknownNCT02721940Not applicable
• 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone MetastasesCompletedNCT02721433Phase 4
• Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot StudyWithdrawnNCT02632903Phase 2
• Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung CancerStatus unknownNCT02622607Phase 3
• Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast CancerStatus unknownNCT02595138Phase 3
• Zoledronic Acid to Maintain Bone Mass After Denosumab DiscontinuationCompletedNCT02499237Phase 4
• Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung CancerStatus unknownNCT02480634Phase 4
• Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant RecipientsWithdrawnNCT02451462Not applicable
• Pre-operative Zoledronate in Triple Negative Breast CancerTerminatedNCT02347163Phase 2
• The Efficacy Study of Aclasta on Prosthetic Fixation in Postmenopausal Women After THAWithdrawnNCT02333344Phase 4
• Prolonged Protection From Bone Disease in Multiple MyelomaCompletedNCT02286830Phase 4
• Zoledronic Acid in Rheumatoid ArthritisTerminatedNCT02123264Phase 3
• Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic AcidWithdrawnNCT02069340Not applicable
• The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast CancerCompletedNCT01907880Phase 4
• Bone Demineralization Lesions in the Injured Marrow: Efficacy and Tolerability of Administration Early and Repeated the Zoledronic Acid. Comparative Study, Prospective, Double-blind Controlled (DBMZol)TerminatedNCT01802658Phase 3
• The Use of Zoledronic Acid to Complex Regional Pain SyndromeStatus unknownNCT01788176Phase 2
• Zoledronic Acid in Cystic FibrosisWithdrawnNCT01702415Phase 4
• The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis ImperfectaTerminatedNCT01679080Phase 2
• Zoledronic Acid to Prevent Bone Loss After Kidney TransplantationCompletedNCT01675089Phase 4
• Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric CancerCompletedNCT01671774Phase 1
• Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast CancerStatus unknownNCT01654367Phase 2/3
• Bone Loss Treatment From Adjuvant Zoledronate EfficacyTerminatedNCT01623908Not applicable
• Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone MassCompletedNCT01572545Not applicable
• Study of AK156 in Primary Osteoporosis PatientsCompletedNCT01522521Phase 3
• Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric NeuroblastomaTerminatedNCT01404702Phase 1
• Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast CancersCompletedNCT01367288Phase 2
• Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Patients With Metastatic Breast Cancer: Duration of EffectCompletedNCT01344967Phase 2/3
• The Effect of Zoledronic Acid to Bone Fusion and Bone Metabolism of Patients With Lumbar Degenerative Disease After Lumbar Interbody FusionStatus unknownNCT01310465Phase 4
• Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCCStatus unknownNCT01259193Phase 2
• Efficacy of Zoledronic Acid in Enhancement of Early Stability of Cementless Primary Hip ProsthesisCompletedNCT01218035Phase 4
• Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer PatientsCompletedNCT01099436Phase 3
• Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical RelapseCompletedNCT01087008Phase 4
• Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major PatientsStatus unknownNCT01016093Phase 2/3
• Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)CompletedNCT01006395Phase 2/3
• Study in Localized and Disseminated Ewing SarcomaCompletedNCT00987636Phase 3
• An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis ImperfectaCompletedNCT00982124Phase 3
• Evaluate the Relationship of Bone Remodeling Markers for Skeletal Complications in Metastatic Breast Cancer PatientsStatus unknownNCT00912938Phase 4
• A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 YearsCompletedNCT00909961Phase 3
• Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas CancerTerminatedNCT00892242Phase 1
• Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT)TerminatedNCT00889590Phase 2
• N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk NeuroblastomaCompletedNCT00885326Phase 1
• Zoledronate for Osteopenia in Pediatric Crohn'sCompletedNCT00798473Phase 3
• Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' CohortCompletedNCT00795483Phase 4
• Osteonecrosis of the Hip and Bisphosphonate TreatmentStatus unknownNCT00781261Phase 2
• Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)CompletedNCT00774020Phase 4
• Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone MetastasisCompletedNCT00762346Phase 4
• Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast CancerCompletedNCT00760370Phase 2
• Feasibility of Doctors' Rooms-based Infusion of Zoledronic AcidCompletedNCT00745485Phase 4
• A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma PatientsCompletedNCT00741377Phase 1
• Stage I Multiple Myeloma TreatmentCompletedNCT00733538Phase 4
• Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic AcidCompletedNCT00731016Phase 2
• Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade OsteosarcomaStatus unknownNCT00691236Phase 2/3
• Androgen Blockade Therapy With or Without Zoledronic Acid in Treating Patients With Prostate Cancer and Bone MetastasesCompletedNCT00685646Phase 3
• Phase 1 Study of Zoledronic Acid in Sickle Cell DiseaseWithdrawnNCT00639392Phase 1/2
• Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer PatientsCompletedNCT00636740Phase 2
• Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone TherapyCompletedNCT00554918Phase 2
• Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast CancerCompletedNCT00525759Phase 2
• Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone MetastasisCompletedNCT00524849Phase 2/3
• Frequency of Zoledronic Acid to Prevent Further Bone Loss in Osteoporotic Patients Requiring Androgen Deprivation Therapy for Prostate CancerCompletedNCT00520052Not applicable
• Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant ChemotherapyCompletedNCT00512993Phase 3
• Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate CancerCompletedNCT00489905Not applicable
• Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone PainCompletedNCT00482378Phase 1/2
• Zoledronic Acid Treatment of Spontaneous Osteonecrosis of the KneeWithdrawnNCT00477217Phase 2
• Combined Chemotherapy With or Without Zoledronic Acid for Patients With OsteosarcomaActive, not recruitingNCT00470223Phase 3
• Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the BoneTerminatedNCT00458796Not applicable
• Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone MetastasesCompletedNCT00434447Phase 4
• Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone MetastasesCompletedNCT00434317Phase 4

← Zoledronic Acid overview